PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.385
+0.015 (0.43%)
Nov 21, 2024, 10:32 AM EST - Market open
PolyPid Employees
As of December 31, 2023, PolyPid had 62 total employees, including 59 full-time and 3 part-time employees. The number of employees increased by 2 or 3.33% compared to the previous year.
Employees
62
Change (1Y)
2
Growth (1Y)
3.33%
Revenue / Employee
n/a
Profits / Employee
-$433,194
Market Cap
23.03M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Allurion Technologies | 504 |
| DarioHealth | 294 |
| Spectral AI | 78 |
| BioXcel Therapeutics | 74 |
| Inspira Technologies Oxy B.H.N. | 42 |
| GlycoMimetics | 35 |
| IN8bio | 31 |
| Tempest Therapeutics | 17 |
PYPD News
- 7 days ago - PolyPid Ltd. (PYPD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - PolyPid to Participate in the Craig-Hallum 15th Annual Alpha Select Conference - GlobeNewsWire
- 22 days ago - PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024 - GlobeNewsWire
- 4 weeks ago - PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery - GlobeNewsWire
- 7 weeks ago - PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections - GlobeNewsWire
- 2 months ago - PolyPid to Participate in Three Upcoming Fall Investor Conferences - GlobeNewsWire
- 3 months ago - PolyPid Ltd (PYPD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds - GlobeNewsWire